The Role of Medical Affairs in Advancing Digital Health

Small, intimate and participant-led discussions tackling digital health challenges. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

Medical affairs (MA) teams play a critical role in communicating with the wider medical fraternity and commercially supporting pharmacologics. The rising adoption of digital health solutions alongside drugs is changing the scope of the traditional medical affairs function in (bio)pharmaceutical companies.

Digital health interventions, to the extent that they influence patient outcomes, are and should be considered as analogous to pharmacological interventions. This realisation has initiated a reflection about the role of medical affairs in the development and evaluation of, as well as the dissemination of evidence pertaining to technology. 

In this meeting, we will discuss how the medical affairs function needs to evolve to address its expanding remit, and the inevitable integration of traditional medicine and technology. Specifically, we will explore the following topics: